Overview
Vaccines are biological preparations that confer active acquired immunity against specific pathogens by presenting the immune system with antigens, derived from or resembling a disease-causing agent, that prime adaptive responses without causing the disease itself. On administration they stimulate the production of antigen-specific antibodies and memory B and T cells, enabling rapid and effective defense upon subsequent natural exposure. Vaccine platforms include inactivated and live-attenuated agents, protein-subunit and conjugate vaccines, viral-vector constructs, and nucleic-acid vaccines such as messenger RNA, each differing in immunogenicity, stability, and manufacturing. Beyond individual protection, widespread vaccination reduces transmission and can establish population-level herd immunity, a principle central to the control of epidemics, while the durability of protection is challenged by waning immunity and pathogen evolution that may necessitate updated formulations. For coronaviruses, vaccines targeting the spike glycoprotein have been deployed against SARS-CoV-2, accompanied by study of dosing, immune dynamics, and safety. The peer-reviewed research collected under this topic spans COVID-19 vaccine dynamics and dosing models, herd-immunity and infection modeling, immune and cytokine responses to spike protein, viral evolution and mutation prediction, and broader analyses of vaccination in pandemic response. Understanding vaccines, their immunological mechanisms, platforms, and population effects, is foundational to immunology, virology, and public health, underpinning the prevention and control of infectious disease.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Dynamics of Infections and Number of Vaccines Needed to Avoid Covid-19 in Europe
The Novel Coronavirus 2019 (COVID-19): A Narrative Review
Features of the Emergence and Re-Emergence of Infectious Diseases, Geopolitics and Gain-of-Function Research
A Data Mining Methodology for Detecting Conspiracy Theories from Scientific Articles: The Covid-19 Case
Exponential Parsimony to Generate Herd Immunity Against SARS- CoV2 Cybernetically Restricting Doxastic and Desiderative Logics
Animals in the COVID-19 Era: Between Being a source, Victims, or Maybe our Hope to Overcome it!
Molecular Evolutionary Characteristics of the 2019 Novel Coronavirus (SARS-CoV-2) Contracted by Tunisian Citizens : Comparison and Relationship to Other Human and Animal Coronaviruses Based on Spike Glycoprotein-Coding Gene Sequences Analysis
Use of Immune Modulator Interferon-Gamma to Support Combating COVID-19 Pandemic
Models and data Analysis of the Outbreak Risk of COVID-19
An Algorithm to Predict the Possible SARS-CoV-2 Mutations
Marginal SARS-CoV-2 Spike Protein Increases Interferon and Balances Cytokine Gene Expression
How this research is being cited
The 12 articles above have been cited 21 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2024 · German Journal of Pharmaceuticals and Biomaterials
-
Satadal Das et al. · 2023 · International Journal of Applied Biology
-
2023 · Frontiers in Medicine
-
2023 · Applied Mathematics and Nonlinear Sciences
-
2023 · Frontiers in Medicine
-
2022 · International Journal of Clinical Virology
-
2022 · International Journal of Clinical Virology
-
2022 · Applied Mathematics and Nonlinear Sciences
A sample of recent works citing this journal's research on Vaccines, linking to each citing work.